Literature DB >> 34189470

Protocol for the preparation of site-specific succinylated histone mimics to investigate the impact on nucleosome dynamics.

Yihang Jing1, Zheng Liu1, Xiang David Li1.   

Abstract

Lysine succinylation is a recently discovered posttranslational modification that plays critical roles in metabolism, epigenetic signaling, and human diseases. To investigate the effects of site-specific histone lysine succinylation on nucleosome dynamics requires the generation of homogeneously modified histones, which is a significant challenge. Here, we report a protocol for the rapid site-specific installation of a succinyl lysine analog onto histone. We then use a Förster resonance energy transfer approach to characterize the impact on nucleosome dynamics. For complete details on the use and execution of this protocol, please refer to Jing et al. (2018).
© 2021 The Authors.

Entities:  

Keywords:  Biophysics; Chemistry; Molecular Biology; Molecular/Chemical Probes; Protein Biochemistry; Protein expression and purification

Mesh:

Substances:

Year:  2021        PMID: 34189470      PMCID: PMC8215284          DOI: 10.1016/j.xpro.2021.100604

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Primer design

Timing: 20 min Primers for preparing the cysteine mutation on histone H2B lysine 34 (H2B K34C). The pET-histone expression plasmids were gifts from Professor Bing Zhu (Institute of Biophysics, Chinese Academy of Sciences, China). H2B K34C is introduced by site-directed mutagenesis using the following primers: Forward: 5′-GGAAAAAGCGCAGGAAGACAAGGTGCGAGAGTTATGCCATTTACG-3′ Reverse: 5′-CGTAAATGGCATAACTCTCGCACCTTGTCTTCCTGCGCTTTTTCC-3′ Primers for preparing fluorophore-labeled DNA fragments. The fluorescein-labeled DNA fragments are prepared by PCR using primers labeled with Alexa 488 and Alexa 594 (IBA, Germany). Both fluorophores are attached via aminolink-C6 linkers. A template of 153 bp “Widom 601” DNA (Lowary and Widom, 1998) is synthesized and incorporated into pcDNA 3.1 vector using EcoRV (Tech Dragon Limited, HK). Below are the sequences of the 153 bp “Widom 601” DNA and fluorophore-labeled primers: DNA 601 (5′-3′): ATCGAGAATCCCGGTGCCGAGGCCGCTCAATTGGTCGTAGACAGCTCTAGCACCGCTTAAACGCACGTACGCGCTGTCCCCCGCGTTTTAACCGCCAAGGGGATTACTCCCTAGTCTCCAGGCACGTGTCAGATATATACATCCGAT Primers for inner fluorophore labeling: Forward: 5′-ATCGAGAATCCCGGTGCCGAGGCCGCT(Alexa 488)CAATTG-3′ Reverse: 5′-ATCGGATGTATATATCTGACACGTGCCT(Alexa 594)GGAGAC-3′ Primers for end fluorophore labeling: Forward: 5′-T(Alexa 488)ATCGAGAATCCCGGTGCCGAGGCCGCTCAATTG-3′ Reverse: 5′-T(Alexa 594)ATCGGATGTATATATCTGAC-3′ fluorophores were labeled at thymine via 5-C6-Amino-dT.

Preparation of fluorophore-labeled DNA fragments

Timing: 2 h The fluorophore-labeled DNA fragments are prepared by PCR using the above-mentioned primers (Primer design) (Gansen et al., 2015, Bohm et al., 2011). Prepare the mix below: Use the following thermocycler parameters for the PCR. The PCR products are then precipitated by isopropyl alcohol, washed in ethanol, and dissolved in histone refolding buffer (2 M NaCl, 10 mM Tris-HCl, pH 7.5, 1.0 mM EDTA, 5 mM β-mercaptoethanol). The concentration of DNA is determined by UV-Vis spectrophotometer (A260 nm, NanoDrop 2000, Thermo).

Key resources table

Materials and equipment

Luria-Bertani (LB) media (storage: 22°C–25°C, make fresh)

Dissolve the following reagents in Milli-Q water to a final volume of 1 L and autoclave the media at 121°C for 30 min.

Lysis buffer (storage: 4°C, make fresh)

To prepare 250 mL of lysis buffer, dissolve the following reagents and bring the volume to 240 mL using Milli-Q water. Adjust the pH to 7.5 using 10 M NaOH solution. Adjust the final volume to 250 mL using Milli-Q water.

HU-0/100/500/1000 buffer (storage: 4°C, make fresh)

To prepare 1 L of HU-0/100/500/1000 buffer, dissolve the following reagents and bring the volume to 980 mL using Milli-Q water. Adjust the pH to 7.5 using 10 M NaOH solution. Adjust the final volume to 1 L using Milli-Q water.

“Thiol-ene” coupling reaction and deprotection reaction buffer (storage: 22°C–25°C, up to 2 months)

To prepare 50 mL of ‘Thiol-ene’ coupling reaction & deprotection reaction buffer, dissolve the following reagents and bring the volume to 45 mL using Milli-Q water. Adjust the pH to 7.0 using 10 M NaOH solution. Adjust the final volume to 50 mL using Milli-Q water.

Histone unfolding buffer (storage: 22°C–25°C, make fresh)

To prepare 50 mL of histone unfolding buffer, dissolve the following reagents and bring the volume to 45 mL using Milli-Q water. Adjust the pH to 7.5 using concentrated HCl solution. Adjust the final volume to 50 mL using Milli-Q water.

Histone refolding buffer (storage: 4°C, make fresh)

To prepare 1 L of histone refolding buffer, dissolve the following reagents and bring the volume to 980 mL using Milli-Q water. Adjust the pH to 7.5 using concentrated HCl solution. Adjust the final volume to 1 L using Milli-Q water.

Histone dimer/tetramer storage buffer (storage: 4°C, make fresh)

To prepare 2 L of histone dimer/tetramer storage buffer, dissolve the following reagents and bring the volume to 1.9 L using Milli-Q water. Adjust the pH to 7.5 using concentrated HCl solution. Adjust the final volume to 2 L using Milli-Q water.

Nucleosome reconstitution buffer (storage: 22°C–25°C, up to 6 months)

To prepare 2 L of nucleosome reconstitution buffer, dissolve the following reagents and bring the volume to 1.9 L using Milli-Q water. Adjust the pH to 7.8 using concentrated HCl solution. Adjust the final volume to 2 L using Milli-Q water.

Stepwise salt dialysis buffer (storage: 4°C, make fresh)

To prepare 500 mL of refolding buffer, dissolve the following reagents and bring the volume to 480 mL using Milli-Q water. Adjust the pH to 7.8 using concentrated HCl solution. Adjust the final volume to 500 mL using Milli-Q water.

Native loading buffer (storage: 4°C, up to 1 year)

To prepare 2 mL of native loading buffer, dissolve the following reagents and bring the volume to 1.9 mL using Milli-Q water. Adjust the pH to 6.8 using concentrated HCl solution. Adjust the final volume to 2 mL using Milli-Q water.

TBE buffer (storage: 22°C–25°C, up to 6 months)

To prepare 1 L of TBE buffer, dissolve the following reagents and bring the volume to 980 mL using Milli-Q water. Adjust the pH to 8.0 using concentrated HCl solution. Adjust the final volume to 1 L using Milli-Q water.

Elution buffer (storage: 4°C, make fresh)

To prepare 1 L of elution buffer, dissolve the following reagents and bring the volume to 980 mL using Milli-Q water. Adjust the pH to 7.8 using concentrated HCl solution. Adjust the final volume to 1 L using Milli-Q water.

FRET experimental high salt buffer (storage: 4°C, make fresh)

To prepare 500 mL of refolding buffer, dissolve the following reagents and bring the volume to 480 mL using Milli-Q water. Adjust the pH to 7.5 using concentrated HCl solution. Adjust the final volume to 500 mL using Milli-Q water.

FRET experimental low salt buffer (storage: 4°C, make fresh)

To prepare 500 mL of refolding buffer, dissolve the following reagents and bring the volume to 480 mL using Milli-Q water. Adjust the pH to 7.5 using concentrated HCl solution. Adjust the final volume to 500 mL using Milli-Q water.

Other buffers

Step-by-step method details

Synthesis of tert-butyl N-vinyl succinamate (compound 1)

Timing: 3 days Synthesis of mono-tert-butyl succinate (Step i in Scheme 1) (Colombo et al., 2012)
Scheme 1

Synthesis of tert-butyl N-vinyl succinamate

Dissolve succinic anhydride (3.00 g, 29.98 mmol), N-hydroxysuccinimide (0.3 eq, 1.04 g, 8.99 mmol), and DMAP (0.1 eq, 366.25 mg, 3.00 mmol) in 40 mL toluene. Add triethylamine (0.3 eq, 910.07 mg, 8.99 mmol) and tert-butyl alcohol (2.0 eq, 4.44 g, 59.96 mmol) into the mixture. Reflux the mixture for 24 h and let it cool to 25°C. Wash the upper organic phase with 1 M HCl solution and followed with brine. Dry the organic phase over Na2SO4 (s), filter, and concentrate under vacuum to give the crude product. Purify the crude product in a flash chromatography column eluted with 9:1 DCM/acetone to afford the product as a yellow oil (4.2 g, 24.11 mmol, 80% yield). Analyze the product by 1H NMR (400 MHz, CDCl3): δ 2.63 (t, J = 6.1 Hz, 2H), 2.54 (t, J = 6.1 Hz, 2H), 1.44 (s, 9H). Synthesis of tert-butyl N-vinyl succinamate Mono-tert-butyl succinate is commercially available (Sigma, cat#547352). Synthesis of tert-butyl succinamate (Step ii in Scheme 1) (Grimm and Lavis, 2011). Dissolve mono-tert-butyl succinate (500 mg, 2.87 mmol), NH4Cl (3.0 eq, 460.59 mg, 8.61 mmol), EDCI (1.5 eq, 825.38 mg, 4.31 mmol), and HOBt (1.5 eq, 659.35 mg, 4.31 mmol) in 10 mL DMF. Add DIEA (1.5 eq, 556.47 mg, 4.31 mmol) into the mixture above. After stirring for 6 h at 25°C, pour the reaction solution into 30 mL saturated NaHCO3 solution and extract with ethyl acetate (3 × 20 mL). Wash the combined organic layers with brine, dry over Na2SO4, filter, and concentrate under vacuum. Purify the crude product in a flash chromatography column eluted with 9:1 DCM/MeOH to afford tert-butyl succinamate as a clear oil (497.18 mg, 2.87 mmol, 100% yield). Analyze the product by 1H NMR (400 MHz, CDCl3): δ 6.43 (s, 1H), 6.30 (s, 1H), 2.39 (t, J = 6.5 Hz, 2H), 2.32 (t, J = 6.5 Hz, 2H), 1.27 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 174.18, 171.63, 79.94, 29.85, 29.60, 27.31; HRMS (EI): calculated for C8H15NO3 (M+): 173.1052, found 173.1057. Synthesis of tert-butyl N-vinyl succinamate (Step iii in Scheme 1) (Compound 1) (Hansen and Skrydstrup, 2005). Dissolve tert-butyl succinamate (100 mg, 0.577 mmol), Cs2CO3 (1.0 eq, 188.10 mg, 0.577 mmol), CuI (0.2 eq, 21.99 mg, 0.115 mmol), vinyl iodide (0.8 eq, 71.10 mg, 0.462 mmol), and N1,N2-dimethylethane-1,2-diamine (0.4 eq, 20.36 mg, 0.230 mmol) in 5 mL anhydrous THF. Stir the reaction mixture for 17 h at 70°C under argon protection. Filter the reaction mixture and concentrate the filtrate under vacuum to afford the crude product. Purify the crude product in a flash chromatography column eluted with 50:50 hexane/ethyl acetate to afford Compound 1 as a yellow oil (60 mg, 301.13 μmol, 52% yield). Analyze the product by 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 8.9 Hz, 1H), 6.91 (m, 1H), 4.56 (dd, J = 15.9 Hz, 1H), 4.33 (dd, J = 8.8 Hz, 1H), 2.53 (t, J = 6.3 Hz, 2H), 2.44 (t, J = 6.3 Hz, 2H), 1.37 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 172.22, 169.61, 128.65, 95.30, 80.93, 30.91, 30.46, 27.97; HRMS (EI): calculated for C10H17NO3 (M+): 199.1208, found 199.1199.

Preparation of recombinant Xenopus laevis histones

Timing: 2 weeks Wild type histones H2A, H2B, H3, and H4 are expressed in Escherichia coli Rosetta strain (DE3) and purified as previously described (Luger et al., 1999). Grow E. coli Rosetta cells harboring pET-histone expression plasmids in 1 L LB media containing ampicillin and chloramphenicol at 37°C until OD600 reaches 0.8. Induce protein expression by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.6 mM and incubate for 4 h at 37°C. Collect the cells by centrifugation at 3,500 × g for 25 min at 4°C. Resuspend the cells in lysis buffer (25 mM HEPES, 1 mM EDTA, 1 M NaCl, 1 mM PMSF, pH 7.5). CRITICAL: For the lysis buffer, 1 mM PMSF is added just before use as it hydrolyses rapidly. Sonicate the cells (5 s ON, 10 s OFF, 30 min) and collect the pellet of the inclusion bodies containing the corresponding histone proteins by centrifugation at 4°C (12,000 × g, 15 min). Resuspend the pellet in 15 mL lysis buffer containing 1% (v/v) Triton X-100 and centrifuge at 12,000 × g for 15 min at 4°C, and then pour off the supernatant. Repeat step f twice and then wash the pellet twice with 15 mL lysis buffer. After final wash, pour off the supernatant. Add 250 μL DMSO to the pellet and incubate for 20 min at 25°C. Add 5 mL HU-500 buffer (6 M Urea, 25 mM HEPES, 1 mM EDTA, 500 mM NaCl, pH 7.5) to the mixture. Add HU-0 buffer (6 M Urea, 25 mM HEPES, 1 mM EDTA, pH 7.5) to the mixture to dilute the salt concentration to 100 mM with shaking. Keep shaking and mixing for another 2 h at 25°C. Centrifuge at 20,000 × g for 10 min at 25°C ( Most of the pellet should be dissolved in the HU buffer). Collect the supernatant and load onto a HiTrap SP HP column (5 mL, GE) pre-equilibrated with HU-100 buffer (6 M Urea, 25 mM HEPES, 1 mM EDTA, 100 mM NaCl, pH 7.5). Elute histone proteins with a gradient of 0%–100% HU-500 buffer over 25 min at a flow rate of 2 mL/min. Analyze the peak fractions by 18% SDS-PAGE and pool the fractions containing the purified histone proteins. Load the combined fractions onto a HiLoad 16/60 Superdex 200 pg size-exclusion column (GE) pre-equilibrated with HU-1000 buffer (6 M Urea, 25 mM HEPES, 1 mM EDTA, 1000 mM NaCl, pH 7.5). Elute histone proteins using 100% HU-1000 buffer at a flow rate of 2 mL/min. Analyze the peak fractions by 18% SDS-PAGE and collect the corresponding fractions. Dialyze the histone proteins against dd H2O containing 2 mM DTT at 4°C (at least three changes). Freeze dry the protein solution to obtain the lyophilized histone powder. Purification of mutated histone H2B K34C will be the same as the preparation of wild type histones. Pause point: Purified histone proteins can be stored at −80°C for an indefinite length of time.

Preparation of modified histone H2BKc34succ-tBu

Timing: 3 days The ‘thiol-ene’ coupling reaction of Compound 1 with mutated histone H2BK34C followed by HPLC purification generates the modified histone H2BKc34succ-tBu (Figure 1A) (Li et al., 2011).
Figure 1

Installation of the succinyl lysine analog onto recombinant histone

(A) Scheme for the installation of the succinyl lysine analog (Kcsucc) at position 34 of histone H2B.

(B and C) LC-MS and deconvolution results for the thiol-ene coupling product H2BKc34succ-tBu (B) and the deprotected final product H2BKc34succ (C). Figure reprinted with permission from Jing et al., 2018.

The ‘thiol-ene’ coupling reaction: Dissolve mutated histone H2BK34C in 0.1 M phosphate buffer (pH 7.0) containing 6 M Gdn·HCl to a final concentration of 1 mM. Add DTT to a final concentration of 5 mM. CRITICAL: DTT stock solution (1 M) should be freshly prepared. Add 50 equivalent (50 mM) of compound 1 into the reaction mixture. Add VA-044 (20 mM) and dimethyl sulfide (100 mM) separately into the reaction mixture. Initiate the reaction by incubating the reaction tube in a 42°C water bath. CRITICAL: Normally, the ‘thiol-ene’ coupling reaction completes in 2 h. Analyze the reaction by LC-MS using a Vydac 218TP C4 column (4.6 mm × 250 mm, Grace Davison) and ESI-MS. The mobile phase is HPLC buffer A and HPLC buffer B. The deconvolution results are obtained using the UniDec software. HPLC purification of the modified histone: After the reaction finishes according to the HPLC analysis (histone H2BK34C should be fully converted to the modified histone H2BKc34succ-tBu), load the reaction mixture onto a semi-prep column (Vydac C4 column, Grace Davison). Elute modified histone with a gradient of 20%–50% HPLC buffer B over 35 min. Analyze the peak fractions by ESI-MS and obtain the deconvolution results of each peak in the UniDec software (Figure 1B). Pool the fractions containing the pure modified histones, followed by lyophilization. Pause point: Purified histone proteins can be stored at −80°C for an indefinite length of time. Installation of the succinyl lysine analog onto recombinant histone (A) Scheme for the installation of the succinyl lysine analog (Kcsucc) at position 34 of histone H2B. (B and C) LC-MS and deconvolution results for the thiol-ene coupling product H2BKc34succ-tBu (B) and the deprotected final product H2BKc34succ (C). Figure reprinted with permission from Jing et al., 2018.

Deprotection of the tert-butyl group on histone H2BKc34succ-tBu

Timing: 2 days The tert-butyl group on histone H2BKc34succ-tBu is deprotected by treating the intermediate protein with TFA, followed by HPLC purification and lyophilization (Figure 1A). Deprotection reaction in 70% TFA: Dissolve the intermediate protein H2BKc34succ-tBu in 0.1 M phosphate buffer (pH 7.0) containing 6 M Gdn·HCl to a final concentration of 5 mM. Keep the above protein solution on ice. Add TFA dropwise to the reaction mixture to a final concentration of 70% (v/v). Incubate the reaction at 25°C with shaking. Monitor the reaction by LC-MS using a Vydac 218TP C4 column (4.6 mm × 250 mm, Grace Davison) and ESI-MS. The mobile phase is HPLC buffer A and HPLC buffer B. The deconvolution results are obtained using the UniDec software. HPLC purification of deprotected histone: After the reaction finishes according to the HPLC analysis (the intermediate protein H2BKc34succ-tBu should be fully deprotected), remove the TFA under a stream of compressed argon. Load the reaction mixture onto a semi-prep column (Vydac C4 column, Grace Davison) and elute deprotected histone with a gradient of 20%–50% HPLC buffer B over 35 min. Analyze the peak fractions by ESI-MS and obtain the deconvolution results of each peak using the UniDec software (Figure 1C). Pool the fractions containing the pure deprotected histones, followed by lyophilization. Pause point: Purified histone proteins can be stored at −80°C for an indefinite length of time.

Preparation of histone H2A-H2B dimers and (H3-H4)2 tetramers

Timing: 2 days H2A-H2B dimers and (H3-H4)2 tetramers are prepared by histone refolding (Figure 2) (Luger et al., 1999).
Figure 2

The elution profile of H2A-H2B dimers and (H3-H4)2 tetramers in the gel-filtration chromatography detected at 280 nm

H2A-H2B dimers eluted out at around 16 mL, according to its molecular weight (26 kD), whereas (H3-H4)2 tetramers eluted out at around 14.1 mL, according to its molecular weight (53 kD). The purity and stoichiometry of the fractions were verified by 18% SDS-PAGE.

Preparation of H2A-H2B dimers: Mix equal molar quantities of H2A and H2B proteins in histone unfolding buffer (6 M Gdn·HCl, 20 mM Tris-HCl, pH 7.5, 1.0 mM EDTA, 10 mM DTT) to a final histone concentration of 1 mg/mL. Incubate the mixture for 30 min on ice. Dialyze the mixture in histone refolding buffer (2 M NaCl, 10 mM Tris-HCl, pH 7.5, 1.0 mM EDTA, 5 mM β-mercaptoethanol) for 4 h at 4°C, and then change the histone refolding buffer and dialyze for another 16 h. Concentrate the refolded dimer solution using an Amicon® Ultra 15 mL centrifugal filter device (Membrane nominal molecular weight limit, 3 kDa) to less than 1 mL. CRITICAL: When performing concentration with the centrifugal filter device, do not concentrate the total volume below 200 μL, or it may result in precipitation. Load the concentrated mixture onto a HiLoad 16/60 Superdex 200 pg column (GE) pre-equilibrated with histone refolding buffer to remove any histone monomers and impurities. Elute histone proteins with histone refolding buffer over 25 min at a flow rate of 1 mL/min. Analyze the peak fractions by 18% SDS-PAGE to verify the quality of the purified dimers and pool the corresponding fractions. Concentrate the pooled fractions using an Amicon® Ultra 15 mL centrifugal filter device (Membrane nominal molecular weight limit, 3 kDa). For long-term storage, dialyze the concentrated fraction in storage buffer (2 M NaCl, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 5 mM β-mercaptoethanol, 50% glycerol). Determine the protein concentration of the assembled H2A-H2B dimers by Bradford Protein Assay kit. Store the assembled H2A-H2B dimers at −20°C. Use the same method to prepare H2A-H2BKc34succ dimers and (H3-H4)2 tetramers. Pause point: Purified histone dimers and tetramers can be stored at −20°C for up to 4 months. The elution profile of H2A-H2B dimers and (H3-H4)2 tetramers in the gel-filtration chromatography detected at 280 nm H2A-H2B dimers eluted out at around 16 mL, according to its molecular weight (26 kD), whereas (H3-H4)2 tetramers eluted out at around 14.1 mL, according to its molecular weight (53 kD). The purity and stoichiometry of the fractions were verified by 18% SDS-PAGE.

Preparation and purification of fluorophore-labeled mononucleosomes

Timing: 2 days Histone dimers and tetramers can be assembled into nucleosomes using salt deposition (Luger et al., 1997) (Figure 3).
Figure 3

Schematics for the stepwise salt dialysis method to reconstitute nucleosomes

The quality and compaction of reconstituted nucleosomes were analyzed by Native-PAGE.

Stepwise salt dialysis: Determine the protein concentration of the assembled histone dimers (modified H2A-H2BKc34succ dimers or unmodified H2A-H2B dimers) and (H3-H4)2 tetramers by Bradford Protein Assay kit. Determine the concentration of fluorophore-labeled DNA by a UV-Vis spectrophotometer (A260 nm, NanoDrop 2000, Thermo). Mix the purified histone dimers (modified H2A-H2BKc34succ dimers or unmodified H2A-H2B dimers) and (H3-H4)2 tetramers with the fluorophore-labeled “Widom 601” DNA (at a molar ratio of dimer : tetramer : DNA = 2 : 1 : 1.2) to a concentration of 2 μM in 50 μL reconstitution buffer (2 M KCl, 10 mM Tris-HCl, pH 7.8, 0.1 mM EDTA). CRITICAL: Test the ratio of dimer, tetramer, and DNA at a much lower concentration (∼30 nM in 30 μL) to confirm nucleosome formation so as not to waste components on a large preparation. Transfer the mixture into a Slide-A-Lyzer MINI dialysis unit (Thermo) and sequentially dialyze at 4°C against reconstitution buffer containing 1.6 M KCl, 1.4 M KCl, 1.2 M KCl, 1.0 M KCl, 0.8 M KCl, 0.5 M KCl, and 0.2 M KCl for 50 min each, followed by 10 mM KCl 12 h. Pause point: The final dialysis step in 10 mM KCl is left to proceed 12 h. Check the quality and compaction of the reconstituted nucleosomes by Native-PAGE (5% TBE gel, acrylamide : Bis = 29 : 1). Stain the gel with ethidium bromide (EB) for 15 min and visualize the nucleosomes under UV using a MyECL Imager system (Thermo Fisher Scientific). Purification of reconstituted nucleosomes: Concentrate the reconstitution mixture to 75 μL using an EMD Millipore Amicon Ultra Centrifugal Filter (Cat#UFC500324, 3 kDa Ultracel, 0.5 mL). Add 25 μL native loading buffer (62.5 mM Tris-HCl, pH 6.8, 40% glycerol, 0.01% Bromophenol Blue) into the concentrated mixture. Purify the reconstituted nucleosomes by Native-PAGE (5% TBE gel, acrylamide : Bis = 60 : 1) using a mini prep cell (Mini Prep Cell, Bio-Rad 1702908). The elutant is monitored by a UV spectrometer (ÄKTA pure protein purification system). Elution buffer contains 10 mM KCl, 10 mM Tris-HCl, 10% glycerol, pH 7.8, 0.1 mM EDTA and running buffer contains 0.2× TBE. Analyze the peak fractions by Native-PAGE (5 % TBE gel, acrylamide : Bis = 29 : 1) and pool the corresponding fractions. The purity of the purified nucleosomes is verified by Native-PAGE (Figure 4).
Figure 4

The final purified nucleosomes (unmodified and H2BKc34succ, as indicated) used in the FRET experiments

After purification, the amount of free DNA was significantly reduced. Figure reprinted with permission from Jing et al., 2018.

The final purified nucleosomes (unmodified and H2BKc34succ, as indicated) used in the FRET experiments After purification, the amount of free DNA was significantly reduced. Figure reprinted with permission from Jing et al., 2018. Concentrate the purified nucleosomes using an Amicon® Ultra 15 mL centrifugal filter device (Membrane nominal molecular weight limit, 3 kDa). Determine the concentration of the purified nucleosomes by UV-Vis spectrophotometer (A260 nm, NanoDrop 2000, Thermo). Store the purified nucleosomes at 4°C until use. Purified nucleosomes can be stored at 4°C for up to 1 week. Schematics for the stepwise salt dialysis method to reconstitute nucleosomes The quality and compaction of reconstituted nucleosomes were analyzed by Native-PAGE.

Förster resonance energy transfer (FRET) analysis of nucleosome dynamics

Timing: 4 h Salt-dependent dissociation of mononucleosomes can be quantified by a single-pair FRET-based approach as described in the literature (Bohm et al., 2011, Gansen et al., 2015). The donor and acceptor fluorophores used here are Alexa Fluor 488 (excitation at 490 nm and emission at 525 nm) and Alexa Fluor 594 (excitation at 590 nm and emission at 617 nm), respectively. FRET sample preparation: Determine the concentration of the purified nucleosomes by UV-Vis spectrophotometer (A260 nm, NanoDrop 2000, Thermo). Dilute the purified nucleosomes in the elution buffer to a final concentration at 1 ng/μL nucleosome. CRITICAL: Do not vortex during the FRET sample preparation step. Use a pipette to homogenize the mixture. Prepare the series of experimental buffers using FRET low salt buffer (10 mM NaCl, 10 mM Tris, 0.1 mM EDTA, pH 7.5, 1 mM ascorbic acid, 0.1 g/L BSA) and FRET high salt buffer (2 M NaCl, 10 mM Tris, 0.1 mM EDTA, pH 7.5, 1 mM ascorbic acid, 0.1 g/L BSA) at different salt concentrations from 0.01 M to 1.6 M (190 μL per sample). Add 10 μL diluted nucleosome solution into each experimental buffer (final total volume for each sample is 200 μL). Incubate the samples in a 384-well microplate (50 μL/well, 3 replicates for each sample) for 5 min at 25°C. FRET measurements: Use a plate reader (Beckman Coulter, DTX 880) to measure fluorescence intensity in each well. Energy transfer changes due to salt-induced nucleosome dissociation can be measured by the emission of the acceptor (Alexa 594) upon donor excitation (Alexa 488). Fluorescence is detected in two spectral windows to yield the signal intensities of the donor () and transfer () channels. FRET data processing and analysis: Correct the intensity of donor () and transfer () using the following equations:Where, and are background intensities of the experimental buffer, is the spectral crosstalk from the donor to the transfer channel, and is the direct excitation of the acceptor dye. The formula for calculating and is described in Gansen et al. (Gansen et al., 2015). The FRET intensity (I) is a measure of energy transfer efficiency and is calculated using the following equation: Input the data into OriginPro 8 using salt concentration as the x-axis and FRET intensity as the y-axis. To measure the salt-dependent dissociation of the mononucleosomes, fit the following sigmoidal function to the experimental curve: Stability of the mononucleosomes is quantified by the parameter and is the salt concentration where the intensity (Y axis) has dropped to half its initial value. Here, X is the salt concentration in M and b describes the slope of the curve at X = . (0) and () are the amplitude and offset of the salt-titration curve.

Expected outcomes

Examples of the expected outcomes of the FRET experiments in this protocol are given in Figure 5. The close proximity of the DNA ends in a fully assembled nucleosome enables efficient FRET, which is lost when the DNA ends are loosened from the nucleosome during dissociation of the H2A-H2B dimers (Figure 5A). Indeed, when titrating salt (NaCl) into the nucleosome solution, we observed a sigmoidal decay in the FRET intensity (Figure 5B). To quantify the nucleosome stability, we used the salt concentration at the transition midpoint of the titration curve (c1/2 value). In addition to monitoring the release of the H2A-H2B dimers, we also examined the effect of H2BK34succ on the dissociation of the (H3-H4)2 tetramer from DNA as the final step in the salt-induced nucleosome disassembly process. To this end, a pair of FRET dyes were placed at two internal sites of the nucleosomal DNA (Figure 5C). The FRET signal showed a similar decay with increasing salt concentration. However, no difference was observed between the unmodified and H2BK34succ nucleosomes (Figure 5D), indicating that succinylation does not destabilize the (H3-H4)2 tetramer-DNA complex.
Figure 5

Expected outcomes of the FRET experiments

(A) Schematics for a FRET-based approach to study salt-induced stepwise nucleosome disassembly using end-labeled nucleosomal DNA.

(B) Plot showing the normalized FRET intensity as a function of salt concentration for the nucleosomes containing unmodified H2B (black trace) and H2BKc34succ (red trace). The salt concentration at which the FRET has decreased by 50% is denoted as c1/2 (n = 3, mean ± SD).

(C) Schematics for a FRET-based approach with internally labeled nucleosomal DNA.

(D) Plot showing the normalized FRET intensity as a function of salt concentration in nucleosomes containing unmodified H2B (black trace) and H2BKc34succ (red trace). The salt concentration at which the FRET has decreased by 50% is denoted as c1/2 (n = 3, mean ± SD). Figure reprinted with permission from Jing et al. (2018).

Expected outcomes of the FRET experiments (A) Schematics for a FRET-based approach to study salt-induced stepwise nucleosome disassembly using end-labeled nucleosomal DNA. (B) Plot showing the normalized FRET intensity as a function of salt concentration for the nucleosomes containing unmodified H2B (black trace) and H2BKc34succ (red trace). The salt concentration at which the FRET has decreased by 50% is denoted as c1/2 (n = 3, mean ± SD). (C) Schematics for a FRET-based approach with internally labeled nucleosomal DNA. (D) Plot showing the normalized FRET intensity as a function of salt concentration in nucleosomes containing unmodified H2B (black trace) and H2BKc34succ (red trace). The salt concentration at which the FRET has decreased by 50% is denoted as c1/2 (n = 3, mean ± SD). Figure reprinted with permission from Jing et al. (2018).

Quantification and statistical analysis

The deconvolution results in the MS analysis were obtained using UniDec software for Windows (University of Oxford, unidec.chem.ox.ac.uk/). All data fitting and statistical analyses were performed using OriginPro 8 for Windows (OriginLab Corporation, www.originlab.com), GraphPad Prism version 5 for Windows (GraphPad Software, www.graphpad.com), and Image J for Windows (National Institutes of Health, imagej.nih.gov/ij/). For the FRET experiments, the normalized FRET intensity was plotted as the mean ± s.d. (n=3). The sigmoidal function and equation used for the curve fit are specified in detail above.

Limitations

This protocol describes a method to generate site-specific succinylation histones mimics, which can be incorporated into mononucleosomes by stepwise salt dialysis. The effects of lysine succinylation on nucleosome stability and dynamics were investigated by a FRET approach. However, there are several limitations to this protocol. First, as N-vinyl-succinamic acid is not stable, we used tert-butyl N-vinyl succinamate (Compound 1) for the thiol-ene coupling reaction, followed by deprotection of the tert-butyl group to afford the desired succinyl lysine analog. However, the ‘two-step’ reaction strategy requires purification by HPLC to extract the modified histone after each step, which increases the workload and decreases the yield. Second, during nucleosome reconstitution, we used a Bradford Protein Assay kit to determine the concentration of assembled H2A-H2B dimers and (H3-H4)2 tetramers. Although the Bradford Protein Assay kit is convenient, it is not very accurate. The accurate concentration and ratio of dimers and tetramers is crucial for nucleosome reconstitution. If available, we would recommend using nanodrop, Qubit™ Protein Assay Kit, or BCA Protein Assay for more accurate protein concentration quantification. Third, we performed the stepwise salt dialysis of the nucleosomal DNA with histone dimers and tetramers against a concentration gradient in a series of reconstitution buffers, with each dialysis step lasting 50 min. In practice, it is recommended to use a peristaltic pump to add low salt dialysis buffer (10 mM KCl) into the initial high salt dialysis buffer (1.6 M KCl) at a steady rate with stirring to gradually decrease the salt concentration. This will not only save you from having to prepare a series of dialysis buffers, but also allows the salt concentration to decrease linearly, which we believe is more favorable for the nucleosome assembly.

Troubleshooting

Problem 1

The ‘thiol-ene’ coupling reaction doesn’t work (step 1).

Potential solution

Disulfide bonds may form between Cys-containing proteins, whereas the ‘thiol-ene’ coupling reaction requires free thiols. Increase the concentration of DTT to 10 mM in the reaction mixture and incubate with proteins for 30 mins at 37°C prior to adding compound 1.

Problem 2

After the ‘thiol-ene’ coupling reaction, the purification of the modified histone is difficult (step 2). Besides the modified histones, DTT can also react with excess compound 1 to form a large number of byproducts. These small molecule impurities can make it difficult to purify the modified histone. Use dialysis to remove the small molecule impurities before HPLC purification. Alternatively, it is possible to use an Amicon® Ultra 15 mL centrifugal filter device (Membrane nominal molecular weight limit, 3 kDa) to remove small molecule impurities prior to HPLC purification.

Problem 3

The reconstitution of nucleosomes by stepwise salt dialysis fails and no clear bands are detected in the Native-PAGE (step 7). The quantification of dimers, tetramers, and DNA may not be accurate. Repeat the quantification of the protein concentration using Bradford Protein Assay kit (use nanodrop, Qubit™ Protein Assay Kit, or BCA Protein Assay for more accurate quantification). Add an additional equivalent of histone dimers to ensure complete consumption of histone tetramers, as histone tetramers may interfere with the purification of nucleosomes. The concentration of DNA can be determined by UV-Vis spectrophotometer at A260 nm, as the ratio of DNA is crucial for nucleosome reconstitution. Normally, 1.2 equivalent of DNA is enough, however, the amount of DNA can be increased to 1.5 equivalent to ensure full assembly.

Problem 4

The FRET curve is not ideal, in particular, the FRET intensity drops quickly at higher salt concentrations (steps 9 and 10). The nucleosomes may disassemble during long-term storage. It is highly recommended to use Native-PAGE (5 % TBE gel, acrylamide : Bis = 29 : 1) to verify the quality of the purified nucleosomes before starting the FRET experiments. After preparing the FRET samples, use a plate reader to measure the fluorescence intensities as soon as possible, as nucleosomes may not be stable after prolonged incubation in the FRET buffer, particularly in the high salt experimental buffer.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to the lead contact, Xiang David Li (xiangli@hku.hk).

Materials availability

All reagents generated in this study are available from the lead contact upon completing a Materials Transfer Agreement.

Data and code availability

No unique datasets or codes were generated in this study.
ReagentAmount
AccuPrime™ Pfx DNA Polymerase8 μL
20 μM forward primer20 μL
20 μM reverse primer20 μL
Template (50 ng/μL)10 μL
MgSO4 (50 mM)10 μL
10× Buffer100 μL
dd H2Oup to 1000 μL
PCR cycling conditions
StepsTemperatureTimeCycles
Initial Denaturation95°C3 min1
Denaturation95°C30 sec30 cycles
Annealing50°C30 sec
Extension68°C25 sec
Final Extension68°C2 min1
Hold4°CForever
REAGENT or RESOURCESOURCEIDENTIFIER
Bacterial and virus strains

DH5α Competent CellsThermo Fisher ScientificCat#18265017
Rosetta (DE3) Competent CellsNovagenCat#0954-3CN

Chemicals, peptides, and recombinant proteins

Fmoc-protected amino acidsGL BiochemN/A
Vinyl iodideAlfa AesarCat#L12656; CAS: 593-66-8
N1,N2-Dimethylethane-1,2-diamineAlfa AesarCat#L02204; CAS: 110-70-3
2,2′-Azobis[2-(2-imidazolin-2-yl) propane] Dihydrochloride (VA-044)TCICat# A3012; CAS: 27776-21-2
Recombinant proteinsThis paperN/A

Critical commercial assays

Bradford assay kitBio-RadCat#500-0006
QIAprep Spin Miniprep KitQIAGENCat#27104
Slide-A-Lyzer™ MINI Dialysis Device, 3.5K MWCO, 0.5 mLThermo Fisher ScientificCat#PI88400

Oligonucleotides

Primers for H2B K34C, see primer designIDTN/A
Primers for fluorophore-labeled DNA fragments, see primer designIBA GmbHN/A

Recombinant DNA

pET-histone expression plasmidsProf. Bing Zhu’s labN/A

Software and algorithms

OriginPro 8OriginLab Corporationhttp://www.originlab.com/
UniDecUniversity of Oxfordhttp://unidec.chem.ox.ac.uk/
GraphPad Prism 5GraphPad Software Inc.http://www.graphpad.com/
ImageJNational Institutes of Healthhttps://imagej.nih.gov/ij/

Other

Bioruptor® SonicatorDiagenodeUCD-300
GENESYS 50 UV-Vis SpectrophotometerThermo Fisher Scientific840-298000
NanoDrop™ 2000/2000c SpectrophotometersNanoDropND-2000/2000C
ÄKTA pure protein purification systemCytiva29383015
High-Performance Liquid ChromatographyWatersWaters 2535 Quaternary Gradient Module; Waters 515 HPLC pump; Waters SFO system Fluidics Organizer; Waters 2767 Sample Manager.
Agilent 6130 Series Quadrupole LC/MS SystemAgilent TechnologiesG6130A
MaxQ™ HP Incubated Tabletop Orbital ShakerThermo Fisher ScientificSHKE420HP
Mini Prep CellBio-Rad1702908
ReagentFinal concentrationAmount
Tryptone10 g/L10 g
Yeast extract5 g/L5 g
NaCl10 g/L10 g
ReagentFinal concentrationAmount
HEPES25 mM1.49 g
EDTA1 mM73.06 mg
NaCl1 M14.61 g
PMSF1 mM43.55 mg
ReagentFinal concentrationAmount
Urea6 M360.36 g
HEPES25 mM5.96 g
EDTA1 mM292.24 mg
NaCl0/100/500/1000 mM0/5.84/29.22/58.44 g
ReagentFinal concentrationAmount
NaH2PO40.1 M599.90 mg
Guanidinium HCl6 M28.66 g
ReagentFinal concentrationAmount
Tris-HCl20 mM121.14 mg
EDTA1 mM14.61 mg
Guanidinium HCl6 M28.66 g
DTT10 mM77.13 mg
ReagentFinal concentrationAmount
Tris-HCl10 mM1.21 g
EDTA1 mM292.24 mg
NaCl2 M116.88 g
β-mercaptoethanol5 mM390.65 mg
ReagentFinal concentrationAmount
Tris-HCl10 mM60.57 mg
EDTA1 mM14.61 mg
NaCl2 M5.84 g
β-mercaptoethanol5 mM19.53 mg
Glycerol50% (v/v)1 L
ReagentFinal concentrationAmount
Tris-HCl10 mM2.42 g
EDTA0.1 mM58.44 mg
KCl2 M298.21 g
ReagentFinal concentrationAmount
Tris-HCl10 mM605.70 mg
EDTA0.1 mM14.61 mg
KCl1.6 M/1.4 M/1.2 M/1.0 M/0.8 M/0.5 M/0.2 M/10 mM59.64 g/52.19 g/44.73 g/37.28 g/29.82 g/18.64 g/7.46 g/372.76 mg
ReagentFinal concentrationAmount
Tris-HCl62.5 mM15.14 mg
Bromophenol Blue0.01% (w/v)200 μL 0.1% stock
Glycerol40% (v/v)0.8 mL
ReagentFinal concentrationAmount
Tris-borate45 mM8.23 g
EDTA1 mM292.24 mg
ReagentFinal concentrationAmount
Tris-HCl10 mM1.21 g
EDTA0.1 mM29.22 mg
KCl10 mM745.51 mg
Glycerol10% (v/v)100 mL
ReagentFinal concentrationAmount
Tris-HCl10 mM605.70 mg
EDTA0.1 mM14.61 mg
NaCl2 M58.44 g
Ascorbic acid1 mM88.06 mg
BSA0.1 g/L50 mg
ReagentFinal concentrationAmount
Tris-HCl10 mM605.70 mg
EDTA0.1 mM14.61 mg
NaCl10 mM292.20 mg
Ascorbic acid1 mM88.06 mg
BSA0.1 g/L50 mg
SolutionContentsStorage
10 M NaOH20 g NaOH, fill up to 50 mL with Milli-Q water22°C–25°C, up to 6 months
1 M DTT stock solution771.27 mg DTT, fill up to 5 mL with Milli-Q water−20°C, up to 6 months
HPLC Buffer A1 mL TFA, fill up to 1 L with Milli-Q water22°C–25°C, up to 2 months
HPLC Buffer B1 mL TFA, fill up to 1 L with 90% acetonitrile (ACN) in Milli-Q water22°C–25°C, up to 2 months
Final salt concentration/MFRET experimental high salt buffer (V/μL)FRET experimental low salt buffer (V/μL)nucleosome solution (V/μL)
0.01019010
0.11018010
0.22017010
0.33016010
0.44015010
0.55014010
0.66013010
0.77012010
0.88011010
0.99010010
1.01009010
1.11108010
1.21207010
1.31306010
1.41405010
1.51504010
1.61603010
  10 in total

Review 1.  Expression and purification of recombinant histones and nucleosome reconstitution.

Authors:  K Luger; T J Rechsteiner; T J Richmond
Journal:  Methods Mol Biol       Date:  1999

2.  A direct method for site-specific protein acetylation.

Authors:  Fupeng Li; Abdollah Allahverdi; Renliang Yang; Gavian Bing Jia Lua; Xiaohong Zhang; Yuan Cao; Nikolay Korolev; Lars Nordenskiöld; Chuan-Fa Liu
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-16       Impact factor: 15.336

3.  New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning.

Authors:  P T Lowary; J Widom
Journal:  J Mol Biol       Date:  1998-02-13       Impact factor: 5.469

4.  Characterization of nucleosome core particles containing histone proteins made in bacteria.

Authors:  K Luger; T J Rechsteiner; A J Flaus; M M Waye; T J Richmond
Journal:  J Mol Biol       Date:  1997-09-26       Impact factor: 5.469

5.  Opposing roles of H3- and H4-acetylation in the regulation of nucleosome structure––a FRET study.

Authors:  Alexander Gansen; Katalin Tóth; Nathalie Schwarz; Jörg Langowski
Journal:  Nucleic Acids Res       Date:  2015-02-18       Impact factor: 16.971

6.  Fast and regioselective Heck couplings with N-acyl-N-vinylamine derivatives.

Authors:  Anders Lindhardt Hansen; Troels Skrydstrup
Journal:  J Org Chem       Date:  2005-07-22       Impact factor: 4.354

7.  Site-Specific Installation of Succinyl Lysine Analog into Histones Reveals the Effect of H2BK34 Succinylation on Nucleosome Dynamics.

Authors:  Yihang Jing; Zheng Liu; Gaofei Tian; Xiucong Bao; Toyotaka Ishibashi; Xiang David Li
Journal:  Cell Chem Biol       Date:  2017-12-14       Impact factor: 8.116

8.  Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.

Authors:  Raffaele Colombo; Michele Mingozzi; Laura Belvisi; Daniela Arosio; Umberto Piarulli; Nives Carenini; Paola Perego; Nadia Zaffaroni; Michelandrea De Cesare; Vittoria Castiglioni; Eugenio Scanziani; Cesare Gennari
Journal:  J Med Chem       Date:  2012-11-19       Impact factor: 7.446

9.  Nucleosome accessibility governed by the dimer/tetramer interface.

Authors:  Vera Böhm; Aaron R Hieb; Andrew J Andrews; Alexander Gansen; Andrea Rocker; Katalin Tóth; Karolin Luger; Jörg Langowski
Journal:  Nucleic Acids Res       Date:  2010-12-21       Impact factor: 16.971

10.  Synthesis of rhodamines from fluoresceins using Pd-catalyzed C-N cross-coupling.

Authors:  Jonathan B Grimm; Luke D Lavis
Journal:  Org Lett       Date:  2011-11-17       Impact factor: 6.005

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.